News
Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
Biotech bank balances were again in focus Monday morning, with Tango Therapeutics cutting preclinical work to stretch its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback